Where does Translate BIO, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Translate BIO, Inc. ranks #2,904 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Translate BIO, Inc. hold?

Translate BIO, Inc. holds 132 US utility patents granted between 2017 and 2025, spanning 22 technology areas.

What is Translate BIO, Inc.'s Innovation Score?

Translate BIO, Inc. has an Innovation Score of 49.0 out of 100 (top 15% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Translate BIO, Inc. focus on?

Translate BIO, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 103 patents. Grants appear in 22 CPC subclasses total.

Is Translate BIO, Inc.'s patent grant rate increasing or decreasing?

Translate BIO, Inc.'s recent grant velocity is +134% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Translate BIO, Inc.'s patents?

Translate BIO, Inc.'s patents average 16.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Translate BIO, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Translate BIO, Inc.

USPTO PatentsView assignee record - 132 granted patents across 22 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Translate ranks #2,904 of 49,997 tracked US assignees by granted-patent volume, with 132 patents across 22 technology areas.

#2,904
of 49,997 US assignees by volume: Top 15%
by Innovation Score (49.0/100): 16.1
avg claims per patent: +134%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2904 · US Corporation #2,904 · 132 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 132 grants
TOP-DECILE #2,904/49,997
PHOTO-FINISH Nippon Paper…
CPC-FOCUS A61K · 22 areas
INNOV-PAR 49.0/100
CLAIMS-RICH 16.1 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +134% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nippon Paper Industries Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Aspire North America · near

49
Kinestral · near

49
LifeNet Health · near

49
NEC Display Solutions · near

49
Translate BIO · this assignee

49
3D Lighting… · lowest

7

What this shows Translate's Innovation Score is 49.0/100 (top 15% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Translate's grants concentrate

Translate BIO, Inc. is a focused PatentsView assignee: 22 CPC subclasses with 78% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2024 (23 grants) versus a trough of 1 in 2017. By volume, Translate sits between Nippon Paper Industries Co., Ltd. and Ashley Furniture Industries, LLC.

Translate's three-year grant acceleration

From 2019–2021 to 2022–2024, Translate BIO, Inc. moved from 53 to 47 grants (0.89x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,527. See the growth leaderboard.

Nippon Paper Indu…

132
Prince Mohammad B…

132
Regalo Internatio…

132
Space Exploration

132
Trinity Bay Equip…

132
Werner

132
Westrock Packagin…

132
Translate BIO ◀

132
Ashley Furniture…

131

What this shows Translate holds 132 patents at rank #2,904, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Translate

By rank, the assignees closest to #2,904 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Translate's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Translate, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (49 here).

Aspire North America LLC 49 NEC Display Solutions, Ltd. 49 Kinestral Technologies, Inc. 49 LifeNet Health 49

Similar claim depth

Nearest assignees by average claims per patent (16.1 here).

Elevance Renewable Sciences, Inc. 16.1 avg Rakuten Mobile, Inc. 16.1 avg Oticon Medical A/S 16.1 avg Victaulic Company 16.1 avg

Translate's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 15% higher than 85% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Translate BIO, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	0.8%
2018	16	12.1%
2019	18	13.6%
2020	14	10.6%
2021	21	15.9%
2022	16	12.1%
2023	8	6.1%
2024	23	17.4%
2025partial year	15	11.4%

Which technologies does Translate BIO, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 103

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 100

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 78

C12Y - Enzymes 67

C07K - Peptides 39

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 27

C07D - Heterocyclic Compounds 17

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 15

C07C - Acyclic OR Carbocyclic Compounds 13

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 9

C07J - Steroids 7

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

B01D - Separation 2

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 2

Top 15 of 22 technology areas

Where it ranks

Overall rank by patents

#2,904

of 49,997 tracked assignees

Innovation Score

49.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Translate BIO, Inc.'s patent record in context - here's where to go next.

Translate BIO, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 78% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #2,904 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Translate BIO, Inc. against Nippon Paper Industries Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 49.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.